GlassScriptPhysician profile
Wendy L Labruno
NPI 1043557945
$2,267.98
in general payments reported to CMS, 2019-2025
22 companies · $432 in 2025
The $432 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $194 · 2022: $851 · 2023: $316 · 2024: $475 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,223.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $647.06 | 2021-2025 | Veozah, Myrbetriq |
| Tolmar, INC. | $251.26 | 2024-2025 | Eligard, Jatenzo |
| Medtronic, INC. | $195.22 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $169.01 | 2023-2025 | Gemtesa |
| Axonics, INC. | $150.25 | 2022-2023 | Axonics |
| Millicent US INC | $147.19 | 2021-2025 | Intrarosa, Femring |
| Coloplast Corp | $124.64 | 2024-2025 | |
| Abc Home Medical Supply, INC. | $74.18 | 2024-2025 | |
| Hollister Incorporated | $72.88 | 2023-2024 | Vapro Pocket, Infyna Chic |
| Urovant Sciences INC | $72.23 | 2021-2022 | |
| Antares Pharma, INC. | $69.66 | 2021-2022 | |
| Pfizer INC. | $48.15 | 2022-2024 | |
| 180 Medical, INC. | $46.56 | 2022-2024 | |
| Mayne Pharma Commercial LLC | $45.92 | 2023 | |
| Endo USA, INC. | $35.15 | 2024-2025 | Xiaflex, Aveed |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $24.31 | 2022 | |
| Axogen | $18.93 | 2025 | |
| Avation Medical, INC. | $18.60 | 2024 | Vivally |
| Boston Scientific Corporation | $16.41 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $14.99 | 2023 | Seglentis |
| Acerus Pharmaceuticals Corporation | $13.00 | 2022 | |
| Dentsply Ih Ab | $12.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Labruno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.